Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-01-04 @ 4:55 AM
Study NCT ID:
NCT00423150
Status:
TERMINATED
Last Update Posted:
2017-06-08
First Post:
2006-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2009-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-30
First Submit QC Date:
None
Study First Post Date:
2007-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-27
Results First Submit QC Date:
None
Results First Post Date:
2010-07-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-12
Last Update Post Date:
2017-06-08
Last Update Post Date Type:
ACTUAL